While MX2 overexpression renders melanoma cells less proliferative,5 previously, it has been shown that activation of the IFN pathway and higher XAF1 expression are associated with increased cell sensitivity to cytotoxic treatments.16, 39. This evidence concerns the gene XAF1 and melanoma.